Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A clinician-level review of NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) supplementation after bariatric surgery, covering absorption, dosing, metabolic rationale, and current evidence.
Read clinical reviewA clinician-level review of nicotinamide mononucleotide and nicotinamide riboside cardiovascular effects, covering vascular aging, blood pressure, lipid metabolism, and the state of human trial data as of 2025.
Read clinical reviewA GRADE-level review of NMN and NR (nicotinamide mononucleotide/riboside) clinical trial evidence covering insulin sensitivity, muscle function, NAD+ levels, cardiovascular markers, and safety. Written for clinicians and informed patients.
Read clinical reviewA clinician-level review of how NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) affect bone density, osteoblast activity, and fracture risk, with primary-literature citations and dosing context.
Read clinical reviewA clinician-reviewed deep dive into how NMN and NR affect cognitive function, NAD+ biology, human trial data, dosing, and safety, with primary-literature citations throughout.
Read clinical reviewA physician-reviewed deep dive into how NMN and NR raise NAD+ levels, what that means for brain function, mood, anxiety, and depression, and what the current human trial data does and does not support.
Read clinical reviewA physician-reviewed breakdown of NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) as NAD+ precursors for muscle preservation, covering clinical trial data, dosing protocols, and who benefits most.
Read clinical reviewA clinician-level review of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) as NAD+ precursors in kidney disease: mechanisms, human trial data, dosing, and real safety signals for renal patients.
Read clinical reviewA physician-reviewed guide to NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) use in autoimmune disease, covering NAD+ biology, immunomodulatory effects, clinical trial data, and practical prescribing considerations.
Read clinical reviewA physician-reviewed guide to NMN and NR microdosing protocols, covering dose ranges tested in human trials, pharmacokinetics, safety data, and what the science does and does not yet support.
Read clinical reviewCan stopping NMN or NR supplementation cause a rebound drop in NAD+ or reversal of benefits? A physician-reviewed clinical review of the evidence, withdrawal physiology, and how to taper safely.
Read clinical reviewA clinician-reviewed guide to how season, circadian biology, UV exposure, and metabolic shifts affect NMN and NR dosing strategies, with primary-literature citations throughout.
Read clinical reviewA physician-reviewed deep dive into how NMN and NR supplementation affects sexual function, hormone balance, vascular health, and libido through NAD+ pathway biology. Includes clinical trial data, dosing guidance, and evidence-based expectations.
Read clinical reviewA physician-reviewed deep dive into how NMN and NR affect sleep architecture, circadian NAD+ cycling, slow-wave sleep, REM duration, and what the current clinical trial data actually support.
Read clinical reviewDoes NMN or NR affect appetite and food cravings? This MD-reviewed guide covers the mechanistic science, human trial data, and clinical context for nicotinamide mononucleotide and nicotinamide riboside on hunger regulation.
Read clinical reviewA clinician-level comparison of compounded and branded nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR): bioavailability, purity, regulatory status, cost, and how to choose based on current trial data.
Read clinical reviewA clinical deep-dive into how NMN and NR raise NAD+ levels, influence mitochondrial function, insulin sensitivity, and whole-body energy expenditure, with primary-literature citations and dosing guidance.
Read clinical reviewA clinician-level review of how NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) affect liver function, NAD+ metabolism, NAFLD/MASLD pathways, and safety signals from human trials.
Read clinical reviewA physician-reviewed deep dive into the clinical evidence for nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) effects on hair growth, skin aging, pigmentation, and barrier function, with real trial data and dosing guidance.
Read clinical reviewA week-by-week clinical guide to NMN and NR supplementation in month one: what the trial data show, when effects appear, typical doses, and what to watch for.
Read clinical reviewA physician-level review of the cancer risk signals associated with NMN and NR supplementation, covering NAD+ biology, preclinical tumor-promotion data, clinical trial safety reports, and practical guidance for patients and prescribers.
Read clinical reviewWhy NMN and NR stop working for some people, and what the evidence says about dose optimization, timing, absorption, and synergistic co-factors to break through a plateau.
Read clinical reviewEvidence-based guidance on whether to stop NMN or NR before surgery, how long to hold, what the pharmacology says, and what the current clinical consensus recommends.
Read clinical reviewBoard-reviewed protocols for timing NMN and NR supplementation around long-haul flights, jet lag, and circadian disruption, with primary-literature citations and dosing frameworks.
Read clinical reviewEvidence-based protocol for resuming nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) supplementation after acute illness, with dosing guidance, timing, contraindications, and the latest trial data.
Read clinical review